These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1742481)

  • 1. Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia.
    Casato M; Laganà B; Antonelli G; Dianzani F; Bonomo L
    Blood; 1991 Dec; 78(12):3142-7. PubMed ID: 1742481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to recombinant alpha interferon therapy in idiopathic mixed cryoglobulinemia: reinduction of remission by natural alpha interferon both in antibody-positive and -negative patients.
    Casato M; Antonelli G; Maggi F; Pucillo LP; Di Lullo L; Leoni M; Currenti M; Dianzani F; Bonomo L
    J Biol Regul Homeost Agents; 1994; 8(2):56-9. PubMed ID: 7863814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.
    Dammacco F; Sansonno D; Han JH; Shyamala V; Cornacchiulo V; Iacobelli AR; Lauletta G; Rizzi R
    Blood; 1994 Nov; 84(10):3336-43. PubMed ID: 7524736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia.
    Mazzaro C; Lacchin T; Moretti M; Tulissi P; Manazzone O; Colle R; Pozzato G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S181-5. PubMed ID: 8730503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.
    Lauta VM; De Sangro MA
    Med Oncol; 1995 Dec; 12(4):223-30. PubMed ID: 8832526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
    Dammacco F; Tucci FA; Lauletta G; Gatti P; De Re V; Conteduca V; Sansonno S; Russi S; Mariggiò MA; Chironna M; Sansonno D
    Blood; 2010 Jul; 116(3):343-53. PubMed ID: 20308602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
    Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
    Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.
    Scagnolari C; Casato M; Bellomi F; De Pisa F; Turriziani O; Coviello R; Pirro MR; Dianzani F; Antonelli G
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):70-7. PubMed ID: 12522042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon in the treatment of mixed cryoglobulinemia.
    Migliaresi S; Tirri G
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S175-80. PubMed ID: 8730502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy.
    Mazzaro C; Franzin F; Tulissi P; Pussini E; Crovatto M; Carniello GS; Efremov DG; Burrone O; Santini G; Pozzato G
    Cancer; 1996 Jun; 77(12):2604-13. PubMed ID: 8640712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocytopenia after combined therapy with interferon and angiotensin-converting enzyme inhibitors: evidence for a synergistic hematologic toxicity.
    Casato M; Pucillo LP; Leoni M; di Lullo L; Gabrielli A; Sansonno D; Dammacco F; Danieli G; Bonomo L
    Am J Med; 1995 Oct; 99(4):386-91. PubMed ID: 7573094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
    Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
    Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
    Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
    N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia.
    Mazzaro C; Pozzato G; Moretti M; Crovatto M; Modolo ML; Mazzi G; Santini G
    Haematologica; 1994; 79(4):342-9. PubMed ID: 7528704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a.
    Bojić I; Lilić D; Radojcić C; Mijusković P
    J Gastroenterol; 1994 Jun; 29(3):369-71. PubMed ID: 8061808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized multicenter clinical trial on the use of interferon -2a plus acitretin versus interferon -2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II.
    Stadler R; Otte HG; Luger T; Henz BM; Kühl P; Zwingers T; Sterry W
    Blood; 1998 Nov; 92(10):3578-81. PubMed ID: 9808550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
    Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
    Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term alpha-IFN treatment.
    Sacchi S; Tabilio A; Leoni P; Riccardi A; Vecchi A; Messora C; Bensi L; Falzetti F; Rupoli S; Ucci G
    Ann Hematol; 1993 May; 66(5):245-6. PubMed ID: 8507719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.
    Ferri C; Marzo E; Longombardo G; Lombardini F; La Civita L; Vanacore R; Liberati AM; Gerli R; Greco F; Moretti A; Monti M; Gentilini P; Bombardieri S; Zignego AL
    Blood; 1993 Mar; 81(5):1132-6. PubMed ID: 8382969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon.
    Mazzaro C; Zorat F; Comar C; Nascimben F; Bianchini D; Baracetti S; Donada C; Donadon V; Pozzato G
    J Rheumatol; 2003 Aug; 30(8):1775-81. PubMed ID: 12913934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.